The new facility will produce biologic drugs and Keytruda, becoming Merck’s first in-house US site to make the blockbuster cancer treatment, the company said.

Summer begins early in Hollywood, on the first weekend in May and that kick-off can make or break that pivotal 123 day ...

Key Takeaways Regeneron Pharmaceuticals stock was among the biggest S&P 500 and Nasdaq decliners Tuesday after the biotech ...

Novartis has a lot cooking with new drug launches, and the company is not letting potential U.S. tariffs on pharmaceuticals ...

Attorney General Pam Bondi traveled to a Drug Enforcement Administration lab to meet with chemists who are tasked with ...

DC isn’t the only place where regulatory burden-boosting policy proposals are garnering bipartisan support. The same ...

Medpace has historically maintained a conservative balance sheet. At year-end 2024, cash and cash equivalents totaled $669 million. Medpace generated nearly $191 million in cash flow from operating ...

The FDA has paused a quality control program for milk and dairy products. Food safety experts are concerned, but they say our ...

Guernsey County Sheriff Jeff Paden announced significant prison sentences for three individuals involved in high-level drug ...

Roche posted higher-than-expected first-quarter sales, driven by robust demand for its key drugs, as the company takes active ...

A team of scientists including UCL researchers has tested four anti-amyloid Alzheimer's therapeutics to find out how the drugs bind to toxic amyloid beta protein to tackle the disease.